First Report of the Resolute Onyx 2.0-mm Zotarolimus-Eluting Stent for the Treatment of Coronary Lesions With Very Small Reference Vessel Diameter

Garg, 2010, Coronary stents: current status, J Am Coll Cardiol, 56, S1, 10.1016/j.jacc.2010.06.007 Schunkert, 1999, Implications of small reference vessel diameter in patients undergoing percutaneous coronary revascularization, J Am Coll Cardiol, 34, 40, 10.1016/S0735-1097(99)00181-3 van der Heijden, 2016, Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: insights from 2-year DUTCH PEERS (TWENTE II) randomized trial, Am Heart J, 176, 28, 10.1016/j.ahj.2016.02.020 Koning, 2001, Stent placement compared with balloon angioplasty for small coronary arteries: in-hospital and 6-month clinical and angiographic results, Circulation, 104, 1604, 10.1161/hc3901.096695 Mehilli, 2006, Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels, Eur Heart J, 27, 260, 10.1093/eurheartj/ehi721 Lansky, 2010, Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial, EuroIntervention, 6, J44, 10.4244/EIJV6SUPJA8 Prasad, 2006, Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality, J Am Coll Cardiol, 48, 1765, 10.1016/j.jacc.2006.04.102 Ramstrom, 1993, Multiarterial coronary artery bypass grafting with special reference to small vessel disease and results in women, Eur Heart J, 14, 634, 10.1093/eurheartj/14.5.634 Moses, 2006, Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial, Am J Cardiol, 98, 1455, 10.1016/j.amjcard.2006.06.047 Teirstein, 2015, Two-year safety and effectiveness of the platinum chromium everolimus-eluting stent for the treatment of small vessels and longer lesions, Catheter Cardiovasc Interv, 85, 207, 10.1002/ccd.25565 Cannon, 2012, The XIENCE nano everolimus eluting coronary stent system for the treatment of small coronary arteries: the SPIRIT Small Vessel trial, Catheter Cardiovasc Interv, 80, 546, 10.1002/ccd.23397 Saito, 2015, Clinical and angiographic evaluation of the resolute zotarolimus-eluting coronary stent in Japanese patients - long-term outcome in the RESOLUTE Japan and RESOLUTE Japan small vessel study, Circ J, 79, 96, 10.1253/circj.CJ-14-0836 Tanimoto, 2007, Two-year clinical outcome after coronary stenting of small vessels using 2.25-mm sirolimus- and paclitaxel-eluting stents: insight into the RESEARCH and T-SEARCH registries, Catheter Cardiovasc Interv, 69, 94, 10.1002/ccd.20907 Turco, 2008, Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberte stent: 1-year results from the TAXUS ATLAS program, J Am Coll Cardiol Intv, 1, 699, 10.1016/j.jcin.2008.09.007 Yeung, 2011, Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: the RESOLUTE US clinical trial, J Am Coll Cardiol, 57, 1778, 10.1016/j.jacc.2011.03.005 Elezi, 1998, Vessel size and long-term outcome after coronary stent placement, Circulation, 98, 1875, 10.1161/01.CIR.98.18.1875 Rathore, 2009, Predictors of angiographic restenosis after drug eluting stents in the coronary arteries: contemporary practice in real world patients, EuroIntervention, 5, 349, 10.4244/V5I3A55 Ardissino, 2004, Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial, JAMA, 292, 2727, 10.1001/jama.292.22.2727 Moreno, 2004, Coronary stenting versus balloon angioplasty in small vessels: a meta-analysis from 11 randomized studies, J Am Coll Cardiol, 43, 1964, 10.1016/j.jacc.2004.01.039 Siontis, 2016, Percutaneous coronary interventions for the treatment of stenoses in small coronary arteries: a network meta-analysis, J Am Coll Cardiol Intv, 9, 1324, 10.1016/j.jcin.2016.03.025 Latib, 2012, A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study, J Am Coll Cardiol, 60, 2473, 10.1016/j.jacc.2012.09.020 Parikh, 2016, Outcomes of stenting extra-small (≤2.25 mm) vessels using the Resolute zotarolimus-eluting stent (R-ZES), EuroIntervention, 12, 1215, 10.4244/EIJV12I10A200 Serruys, 2010, Comparison of zotarolimus-eluting and everolimus-eluting coronary stents, N Engl J Med, 363, 136, 10.1056/NEJMoa1004130